Etanercept is minimally effective in 2 children with atopic dermatitis [7]

Journal of the American Academy of Dermatology

Volumn 53, Issue 2, 2005, Pages 358-359

  Buka, Robert L ^a,b   Resh, Brooke ^c   Roberts, Brandie ^a,b   Cunningham, Bari B ^a,b   Friedlander, Sheila ^a,b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETANERCEPT;

ANTIBODY RESPONSE; ATOPIC DERMATITIS; CASE REPORT; CELLULAR IMMUNITY; CHILD; CHILDHOOD DISEASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG MEGADOSE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INFECTION SENSITIVITY; LETTER; LOW DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PSORIASIS; SCORING SYSTEM; SKIN DISEASE; STAPHYLOCOCCUS INFECTION; SUPERINFECTION; TREATMENT OUTCOME; URTICARIA;

EID: 22144486924     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.03.013     Document Type: Article

References (4)

1. B. Goffe, and J.C. Cather Etanercept: An overview J Am Acad Dermatol 49 suppl 2 2003 S105 S111
2. M. Grewe, C.A. Bruijnzeel-Koomen, E. Schopf, T. Thepen, A.G. Langeveld-Wildschut, and T. Ruzicka A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis Immunology Today 19 1998 359 361
3. P.J. Mease, B.S. Goffe, J. Metz, A. VanderStoep, B. Finck, and D.J. Burge Etanercept in the treatment of psoriatic arthritis and psoriasis a randomised trial Lancet 356 2000 385 390
4. J.M. Hanifin, M. Thurston, M. Omoto, R. Cherill, S.J. Tofte, and M. Graeber The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group Exp Dermatol 10 2001 11 18